Status:
TERMINATED
Applied Relaxation for Vasomotor Symptoms
Lead Sponsor:
Elizabeth Nedstrand
Conditions:
Menopause
Hot Flashes
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The objectives of this study are to compare frequency and severity of moderate to severe vasomotor symptoms in postmenopausal women treated with applied relaxation (AR) with an untreated control-group...
Detailed Description
Approximately 70% of women in Europe and North America experience hot flashes and night sweats during the climacteric period. Many women abstain from hormonal therapy because of side effects or contra...
Eligibility Criteria
Inclusion
- postmenopausal women (at least 12 months since last menstrual bleeding occurred or in previously hysterectomised women a serum follicle-stimulating hormone (S-FSH) defined as postmenopausal level according to references at the local laboratory)
- More or equal to 7 moderate to severe hot flashes or more or equal at 50 hot flashes per week according to a two-week screening diary
- ability to understand and speak Swedish
- freely given informed consent
Exclusion
- unstable thyroid or other metabolic disease
- treatment with hormone therapy (HT) or other complementary- or alternative treatments treatment for menopausal-related symptoms
- treatment with psychopharmacological drugs and/or sedatives d-un-treated psychiatric disease
- frequently exercising women (≥ 2h high-intensity activities/week)
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01488864
Start Date
March 1 2007
End Date
September 1 2010
Last Update
May 11 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, Dept of Obstetrics and Gynecology
Linköping, Sweden, 5851 85